MiMedx Group MDXG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.86M-255% | $15.19M+104% | $16.75M+113% | $9.62M-45.4% | $7.02M-22.5% | ||
| -$1.7M-140% | $2.46M-47.5% | $4.92M+29.1% | $4.75M+16.2% | $4.26M-1.8% | ||
| $4.53M+830% | -$2.05M+12.0% | -$5.75M-105% | -$287K+94.6% | -$621K+69.4% | ||
| $1.46M+97.3% | $3.37M+641% | $2.06M+837% | $351K+59.5% | $742K+273% | ||
| -$28.21M-492% | $887K-60.6% | $11.01M+1,056% | $7.29M+282% | $7.2M+115% | ||
| $889K+238% | —— | $1.61M— | $820K+23.7% | $263K-91.1% | ||
| $1.94M+32.6% | —— | $2.91M+379% | —— | $1.46M+416% | ||
| -$375K-414% | —— | $284K+117% | $3.6M+1,472% | -$73K-114% | ||
| -$2.01M-295% | $3.12M— | $3.44M— | $1.23M+165% | $1.03M+3.1% | ||
| $250K+57.2% | $1.47M— | -$110K— | -$1.23M+1.2% | $159K+182% | ||
| $118K-28.9% | $98K-11.7% | $249K-49.6% | $128K— | $166K— | ||
| $330K+7.5% | $325K-3.8% | $318K-3.9% | $312K-3.7% | $307K-3.2% | ||
| $1.88M-64.5% | $24.96M+32.9% | $29.33M+49.5% | $14.42M-33.9% | $5.3M-11.4% | ||
| $570K+51.2% | $285K+8.4% | $192K+12.3% | $179K+70.5% | $377K-67.0% | ||
| $5M— | $0-100% | $3.06M— | $700K+91.3% | $0-100% | ||
| -$5.64M-1,290% | -$335K+87.9% | -$5.26M— | -$887K+2.0% | -$406K+93.3% | ||
| $1.9M-22.7% | $51K+70.0% | $83K-24.5% | $526K+50.7% | $2.46M+14.2% | ||
| -$2.59M+10.2% | -$583K-45.8% | -$857K— | -$1.09M-205% | -$2.88M+91.4% | ||
| -$6.35M-415% | $24.04M+53.9% | $23.21M+17.5% | $12.44M-39.5% | $2.02M+106% | ||
| $4.53M+830% | -$2.05M+12.0% | -$5.75M-105% | -$287K+94.6% | -$621K+69.4% | ||
| -$15.71M-286% | $3.42M-2.3% | $6.36M+54.8% | $3.28M+1,320% | -$4.07M+8.3% | ||
| -$2.01M-295% | $3.12M— | $3.44M— | $1.23M+165% | $1.03M+3.1% | ||
| $330K+7.5% | $325K-3.8% | $318K-3.9% | $312K-3.7% | $307K-3.2% | ||
| $1.46M+97.3% | $3.37M+641% | $2.06M+837% | $351K+59.5% | $742K+273% | ||
| —— | $522.25K+5,397% | $522.25K+5,397% | $522.25K+5,397% | $522.25K+5,397% | ||
| $5M— | $0-100% | $3.06M— | $700K+91.3% | $0-100% | ||
| $570K+51.2% | $285K+8.4% | $192K+12.3% | $179K+70.5% | $377K-67.0% | ||
| —— | $0+100% | $0+100% | $0+100% | $0+100% | ||
| $1.62M-49.5% | —— | $5.29M+358% | $3.17M— | $3.2M— | ||
| $309K+81.8% | $282K+253% | $524K— | $318K— | $170K— | ||
| $72K+148% | —— | $2K— | $8K-98.2% | $29K+124% | ||
| -$375K-50.0% | $1.75M0.0% | -$250K0.0% | -$250K0.0% | -$250K0.0% | ||
| $1.31M-73.4% | $24.67M+33.2% | $29.14M+49.8% | $14.24M-34.4% | $4.92M+1.8% | ||
| $1.31M-73.4% | $24.67M+33.2% | $29.14M+49.8% | $14.24M-34.4% | $4.92M+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MiMedx Group generate?
- MiMedx Group (MDXG) generated $70.6M in operating cash flow over the trailing twelve months.
- What is MiMedx Group's free cash flow?
- After $1.2M of capital expenditures, MiMedx Group's free cash flow was $69.4M over the trailing twelve months, up 7.4% year over year.
- Where does MiMedx Group's cash flow data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
